Biomarin Pharmaceutical Inc (BMRN)

CIK 1048477 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Biomarin Pharmaceutical Inc.

Recent SEC filings

FiledFormAccession number
Sep 3, 202640001628280-26-060572
Sep 2, 20261440001959173-26-006644
Sep 1, 20268-K0001193125-26-377696
Aug 31, 20268-K0001193125-26-375275
Aug 18, 20268-K0001193125-26-354780
Aug 6, 20268-K0001048477-26-000015
Aug 6, 202610-Q0001048477-26-000016
Aug 6, 2026S-80001193125-26-338468
Jul 13, 20268-K/A0001048477-26-000011
Jun 4, 202640001628280-26-040903
Jun 4, 202640001628280-26-040916
Jun 4, 202640001628280-26-040911
Jun 4, 202640001628280-26-040909
Jun 4, 20268-K0001628280-26-040812
Jun 4, 202640001628280-26-040920
Jun 4, 202640001628280-26-040907
Jun 4, 202640001628280-26-040918
Jun 4, 202640001628280-26-040922
Jun 4, 202640001628280-26-040914
May 21, 202640001628280-26-037455
May 11, 202640001628280-26-033639
May 7, 20261440001959173-26-003374
May 5, 202610-Q0001048477-26-000008
May 4, 20268-K0001048477-26-000006
Apr 29, 2026SCHEDULE 13G0002100119-26-000245